Advanced Cell Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- Advanced Cell Diagnostics's estimated annual revenue is currently $36.4M per year.
- Advanced Cell Diagnostics received $22.0M in venture funding in June 2015.
- Advanced Cell Diagnostics's estimated revenue per employee is $193,750
- Advanced Cell Diagnostics's total funding is $40.8M.
Employee Data
- Advanced Cell Diagnostics has 188 Employees.
- Advanced Cell Diagnostics grew their employee count by -4% last year.
Advanced Cell Diagnostics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | Senior Director (IVD) Product Development | Reveal Email/Phone |
3 | Manager, Image Analysis - Machine Learning and Software Development | Reveal Email/Phone |
4 | Product Manager | Reveal Email/Phone |
5 | Field Applications Manager | Reveal Email/Phone |
6 | Manager, Service Project Management | Reveal Email/Phone |
7 | Manager Manufacturing Sciences | Reveal Email/Phone |
8 | Materials Manager | Reveal Email/Phone |
9 | Product Transfer Manager | Reveal Email/Phone |
10 | Associate Lab Manager | Reveal Email/Phone |
Advanced Cell Diagnostics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Advanced Cell Diagnostics?
ACD - a Bio-Techne brand, (www.acdbio.com) shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and tissue-based research and diagnostic tests for personalized medicine. Based in Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry. ACD's products and pharma assay services are based on its proprietary RNAscope® technology ( 1200+ publications in 6 years), the first multiplex fluorescent and chromogenic in situ hybridization platform, capable of detecting and quantifying single molecules of RNA in situ. ACD has two product lines, namely RNAscope and BaseScope(tm) in addition to a Pharma Assay Services business. The catalog includes >10,000 target probes and assay kits for single, duplex and multiplex RNA analysis. www.acdbio.com
keywords:N/A
$40.8M
Total Funding
188
Number of Employees
$36.4M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Advanced Cell Diagnostics News
... Analysis and Major Factors Forecast Report till 2028 Trending Research Report AVIVA BioSciences, AdnaGen, Advanced Cell Diagnostics,...
Advanced Cell Diagnostics Inc., Aviva Biosciences, Creatv Microtech Menarini Silicon Biosystems, Qiagen NV, Miltenyi Biotec, Biocept Inc.,...
Advanced Cell Diagnostics, Inc. Aviva Biosciences. Biocept Inc. Creatv Micro Tech, Inc. LungLife AI, Inc.
Advanced Cell Diagnostics, Inc. (ACD), a Hayward, California-based leader in the field of in situ nucleic acid detection for life science research and clinical diagnostics, raised $22m in Series C equity financing. The round was led by growth equity investor Summit Partners with participation f ...
Advanced Cell Diagnostics Inc. (ACD), a Hayward, CA-based life science research and clinical diagnostics company, has raised $12m in Series B financing. Backers include New Leaf Venture Partners and Morningside Ventures. The company intends to use the capital to expand its commercial efforts f ...
Other Companies in Newark
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.9M | 189 | 42% | N/A |
#2 | $24.9M | 189 | 42% | N/A |
#3 | $56.7M | 191 | 17% | N/A |
#4 | $7.5M | 195 | 8% | N/A |
#5 | $31.6M | 198 | 8% | N/A |
Advanced Cell Diagnostics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2009-09-03 | $5.4M | Undisclosed | Morningside Ventures | Article |
| 2012-11-02 | $12.0M | Undisclosed | New Leaf Venture Partners, Morningside Ventures | Article |
| 2015-06-19 | $22.0M | C | Summit Partners | Article |